Drug General Information
Drug ID
D0TW3L
Former ID
DIB010191
Drug Name
CD20Bi aATC
Synonyms
CD20Bi aATC; CD20Bi activated T-cells (non-Hodgkin's lymphoma), Wayne State University/Barbara Ann Karmanos Cancer Institute; CD20Bi-armed ATC (non-Hodgkin's lymphoma), Wayne State University/Barbara Ann Karmanos Cancer Institute; Anti-CD3/anti-CD20 bispecific antibody-armed activated T-cells (non-Hodgkin's lymphoma); Anti-CD3/anti-CD20 bispecific antibody-armed activated T-cells (non-Hodgkin's lymphoma), Wayne State University/Barbara Ann Karmanos Cancer Institute
Indication Non-hodgkin's lymphoma [ICD10:C85] Phase 1 [544343]
Company
Barbara Ann Karmanos Cancer Institute
Target and Pathway
Target(s) T-cell surface glycoprotein CD3 Target Info Modulator [544343]
B-lymphocyte antigen CD20 Target Info Modulator [544343]
KEGG Pathway Hematopoietic cell lineage
References
Ref 544343CD20-Targeted T Cells after Stem Cell Transplantation for High Risk and Refractory Non-Hodgkin's Lymphoma. Biol Blood Marrow Transplant. 2013 June; 19(6): 925-933.
Ref 544343CD20-Targeted T Cells after Stem Cell Transplantation for High Risk and Refractory Non-Hodgkin's Lymphoma. Biol Blood Marrow Transplant. 2013 June; 19(6): 925-933.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.